Antigen presentation defects in tumors are prevalent mechanisms of adaptive immune evasion and resistance to cancer immunotherapy, whereas how tumors evade innate immunity is less clear. Using CRISPR screens, we discovered that IGSF8 expressed on tumors suppresses NK cell function by interacting with human KIR3DL2 and mouse Klra9 receptors on NK cells. IGSF8 is normally expressed in neuronal tissues and is not required for cell survival in vitro or in vivo. It is overexpressed and associated with low antigen presentation, low immune infiltration, and worse clinical outcomes in many tumors. An antibody that blocks IGSF8-NK receptor interaction enhances NK cell killing of malignant cells in vitro and upregulates antigen presentation, NK cell-mediated cytotoxicity, and T cell signaling in vivo. In syngeneic tumor models, anti-IGSF8 alone, or in combination with anti-PD1, inhibits tumor growth. Our results indicate that IGSF8 is an innate immune checkpoint that could be exploited as a therapeutic target.
Pubmed ID: 38657602 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD90/CD90.1
View all literature mentionsThis monoclonal targets Rabbit n/a
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis isotype control targets Not Applicable
View all literature mentionsThis isotype control targets Not Applicable
View all literature mentionsThis isotype control targets Unknown Specificity
View all literature mentionsThis monoclonal targets PD-1 (CD279)
View all literature mentionsThis monoclonal targets Ly-49I
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD8β (Lyt 3.2)
View all literature mentionsThis monoclonal targets NK1.1
View all literature mentionsThis isotype control targets
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets CD11c
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets NK-1.1
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets F4/80
View all literature mentionsThis monoclonal targets CD19
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD11b
View all literature mentionsThis monoclonal targets CD158e1
View all literature mentionsThis recombinant monoclonal targets MHC class I + HLA A + HLA B
View all literature mentionsThis isotype control targets Unknown Specificify
View all literature mentionsThis monoclonal targets PD-1 (CD279)
View all literature mentionsThis monoclonal targets CD158b/j
View all literature mentionsThis monoclonal targets IgG
View all literature mentionsThis monoclonal targets Perforin
View all literature mentionsThis monoclonal targets CD85j
View all literature mentionsThis monoclonal targets CD14
View all literature mentionsThis monoclonal targets CD107a
View all literature mentionsThis monoclonal targets CD8
View all literature mentionsThis unknown targets Human IGSF8
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets pan Cytokeratin
View all literature mentionsThis monoclonal targets IgG Fc
View all literature mentionsThis monoclonal targets IgG Fc
View all literature mentionsThis monoclonal targets IgG Fc
View all literature mentionsThis polyclonal targets IGSF8
View all literature mentionsThis monoclonal targets CD56
View all literature mentionsThis monoclonal targets CD56
View all literature mentionsThis monoclonal targets Beta-2 microglobulin
View all literature mentionsThis monoclonal targets CD3
View all literature mentionsThis monoclonal targets CD56
View all literature mentionsThis monoclonal targets KIR3DL2/CD158k
View all literature mentionsThis monoclonal targets HLA-F
View all literature mentionsThis monoclonal targets HLA-E
View all literature mentionsThis monoclonal targets HLA-A
View all literature mentionsThis monoclonal targets HLA-G
View all literature mentionsCell line CT26.WT is a Cancer cell line with a species of origin Mus musculus
View all literature mentionsCell line LL/2 (LLC1) is a Cancer cell line with a species of origin Mus musculus
View all literature mentionsCell line B16-F10 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line NCI-H520 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line EMT6 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsCell line A-375 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line VMM17 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line K-562 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line AGS is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line COLO 205 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsStatistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentionsSoftware for single-cell flow cytometry analysis. Its functions include management, display, manipulation, analysis and publication of the data stream produced by flow and mass cytometers.
View all literature mentionsFlow cytometry analysis software.
View all literature mentions